BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24010912)

  • 1. PET/CT in gynecologic malignancies.
    Brunetti J
    Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
    Banks KP; Song WS
    Radiol Clin North Am; 2013 Sep; 51(5):799-831. PubMed ID: 24010907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Assessment of Gynecologic Malignancies.
    Tripathy S; Parida GK; Kumar R
    PET Clin; 2018 Apr; 13(2):269-288. PubMed ID: 29482754
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
    De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
    Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI in Gynecologic Malignancy.
    Larson M; Lovrec P; Sadowski EA; Pirasteh A
    Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging in gynecologic malignancies.
    Kumar R; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1155-67, ix. PubMed ID: 15488564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
    Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
    Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecological cancers.
    Avril N; Gourtsoyianni S; Reznek R
    Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
    Husain A; Akhurst T; Larson S; Alektiar K; Barakat RR; Chi DS
    Gynecol Oncol; 2007 Jul; 106(1):177-80. PubMed ID: 17477959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT and cross sectional imaging of gynecologic malignancy.
    Iyer RB; Balachandran A; Devine CE
    Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S130-8. PubMed ID: 17921092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
    Escott EJ
    Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography-computed tomography imaging for malignancies in women.
    Viswanathan C; Bhosale PR; Shah SN; Vikram R
    Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET Assessment of Other Gynecologic Cancers.
    Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
    PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
    Dalla Palma M; Gregianin M; Fiduccia P; Evangelista L; Cervino AR; Saladini G; Borgato L; Nicoletto MO; Zagonel V
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):84-98. PubMed ID: 22245509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel imaging modalities in gynecologic cancer.
    Brooks RA; Powell MA
    Curr Oncol Rep; 2009 Nov; 11(6):466-72. PubMed ID: 19840524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's New in Imaging for Gynecologic Cancer?
    Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
    Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography in gynecologic cancer.
    Yen TC; Lai CH
    Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.